Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib

Completed · Phase 1

Conditions studied: Healthy Subjects

In brief

The purpose of this study is to examine whether co-administration of rifampin with neratinib has an effect on the pharmacokinetics (how the body absorbs, distributes, metabolizes and/or excretes) of neratinib.

Key facts

Study ID

NCT00864487

Run by

Puma Biotechnology, Inc.

People needed

24

Starts

2009-04-01

Expected to finish

2009-05-01

Last updated by the study team

2012-05-14

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy men or women (of non childbearing potential)
• Ages 18 to 50 years old.

Where it is running

• Study site — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.